Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Diastereoselective synthesis, activity and chiral stability of cyclic alkoxyketone inhibitors of cathepsin KA E Fenwick, A D Gribble, R J Ife, et al.
Health Technology Assessment (Winchester, England)|July 27, 2007
Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analysesT Colbourn, C Asseburg, L Bojke, et al.
Health Technology Assessment (Winchester, England)|May 29, 2010
Alitretinoin for the treatment of severe chronic hand eczemaM Paulden, M Rodgers, S Griffin, et al.
British Journal of Anaesthesia|October 12, 2010
Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluationF Paton, M Paulden, D Chambers, et al.
British Journal of Anaesthesia|October 13, 2010
Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessmentD Chambers, M Paulden, F Paton, et al.
British Journal of Cancer|May 27, 2015
Modelling the cost-effectiveness of public awareness campaigns for the early detection of non-small-cell lung cancerS Hinde, C McKenna, S Whyte, et al.
Dalton Transactions (Cambridge, England : 2003)|February 11, 2005
The nature of aryloxide and arylsulfide ligand bonding in dimethyltitanium complexes containing cyclopentadienyl ligationThomas A Manz, Andrew E Fenwick, Khamphee Phomphrai, et al.
Health Technology Assessment (Winchester, England)|October 22, 2003
A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel diseaseA Kennedy, E Nelson, D Reeves, et al.
BMJ (Clinical Research Ed.)|August 25, 2001
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategiesR E Gilbert, C Augood, R Gupta, et al.
Health Technology Assessment (Winchester, England)|November 27, 2012
Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence developmentK Claxton, S Palmer, L Longworth, et al.
Pageof 12